(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CAHTALOG

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CAHTALOG

ST13

US500000088918310

Class

35, 42, 44

Filing

88918310

Registration

7689391

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

56

Latest update

03/26/2025

Trademark type

Word

Nice classes

35, 42, 44

Filing date

05/15/2020

Registration date

02/11/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/11/2025

Last transaction

03/26/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

02/16/2024

First use in commerce

02/16/2024

Drawing code

4

Owner type

03

Owner location

San Diego, CA

Examiner

MASON,JARED MICHAEL

Law office

N10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Neurocrine Biosciences, Inc.

Representatives

Allison Strickland Ricketts FROSS ZELNICK LEHRMAN & ZISSU, P.C.

Technical classification

Nice Classes

Class 35Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Promoting the interests of people who have congenital adrenal hyperplasia and their families and health care providers by means of public advocacy; maintaining a registry of patients with congenital adrenal hyperplasia; Updating and maintenance of information in registriesadministering a patient registry for patients with congenital adrenal hyperplasia

Class 42

Medical and scientific research services; providing an online computer database that contains data on clinical outcomespatient reported outcomesclinician-reported outcomeshealth care resource utilization for medical and scientific research purposes; providing information in the field of medical and scientific research featuring a registry of patients with congenital adrenal hyperplasia; administering a scientific advisory committee in the nature of providing scientific advice and scientific consultation relating to congenital adrenal hyperplasia;

Class 44

Providing medical information; providing a website featuring a registry of patients with congenital adrenal hyperplasia for medical treatment purposes; providing medical and health information to consumerspatientsdoctorscaregivers in the field of congenital adrenal hyperplasia

Publications

History of USPTO decisions and trademark events.

56 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/20/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/20/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/20/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/20/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

03/20/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/11/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

02/11/2025

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

01/17/2025

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

01/17/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/17/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/17/2025

ALIE

ASSIGNED TO LIE

01/17/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/24/2024

XELG

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

11/25/2024

XELR

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

11/25/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/27/2024

GNRT

NON-FINAL ACTION E-MAILED

08/27/2024

CNRT

SU - NON-FINAL ACTION - WRITTEN

08/27/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

05/22/2024

IUAF

USE AMENDMENT FILED

05/20/2024

EISU

TEAS STATEMENT OF USE RECEIVED

05/20/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

11/14/2023

EX5G

SOU EXTENSION 5 GRANTED

11/13/2023

EXT5

SOU EXTENSION 5 FILED

11/08/2023

EEXT

SOU TEAS EXTENSION RECEIVED

11/08/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/20/2023

EX4G

SOU EXTENSION 4 GRANTED

05/19/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

05/19/2023

EXT4

SOU EXTENSION 4 FILED

05/16/2023

EEXT

SOU TEAS EXTENSION RECEIVED

05/16/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

11/16/2022

EX3G

SOU EXTENSION 3 GRANTED

11/14/2022

EXT3

SOU EXTENSION 3 FILED

11/14/2022

EEXT

SOU TEAS EXTENSION RECEIVED

11/14/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/20/2022

EX2G

SOU EXTENSION 2 GRANTED

05/18/2022

EXT2

SOU EXTENSION 2 FILED

05/18/2022

EEXT

SOU TEAS EXTENSION RECEIVED

05/18/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

11/18/2021

EX1G

SOU EXTENSION 1 GRANTED

11/16/2021

EXT1

SOU EXTENSION 1 FILED

11/16/2021

EEXT

SOU TEAS EXTENSION RECEIVED

11/16/2021

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

05/18/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/23/2021

PUBO

PUBLISHED FOR OPPOSITION

03/23/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/03/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/17/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/12/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/12/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/12/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/13/2020

GNRT

NON-FINAL ACTION E-MAILED

08/13/2020

CNRT

NON-FINAL ACTION WRITTEN

08/13/2020

DOCK

ASSIGNED TO EXAMINER

08/13/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/29/2020

NWAP

NEW APPLICATION ENTERED

05/19/2020

Continuous trademark protection

Get notified about every new filing that threatens CAHTALOG or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.